Circulating tumor DNA in breast cancer: From technological foundation to clinical implementation.

已取消 10 由达姆发布于 2026/2/24 14:46:35

DOI:10.1016/j.ctrv.2026.103108
作者：Xinyi Lin,?Baiying Liu,?Jing Wu,?Lina Shi,?Yanyan Zhang,?Qiaoyu Yang,?Haiyun Tang,?Shaoting Xu,?Yuxuan Gao,?Jihong Cui,?Yunjian Zhang
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Circulating tumor DNA (ctDNA)-based liquid-biopsy has emerged as a transformative tool in breast cancer management, offering non-invasive, real-time insights across the clinical continuum. B

应助信息

2026-02-24

Book学术机器人

2026/2/24 14:46:35 未找到该文献，机器人已退出，请等待人工下载

2026/2/24 14:46:35 Book学术AI机器人收到请求，开始寻找文献

2026/2/24 14:46:35 已向机器人发送请求

2026-02-24

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:JAMAOverall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer